Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
6.71
-0.02 (-0.30%)
Nov 17, 2026, 3:00 PM CST

SHA:603229 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.53130.57206.79253.9235.38145.93
Depreciation & Amortization
73.9673.9663.6640.5934.4830.02
Other Amortization
0.230.23----
Loss (Gain) From Sale of Assets
----1.580.52
Asset Writedown & Restructuring Costs
1.481.480.155.624.955.24
Loss (Gain) From Sale of Investments
-22.28-22.28-28.05-0.4-5.4-7.9
Provision & Write-off of Bad Debts
-4.32-4.327.260.34--
Other Operating Activities
92.5948.775.46-3.68-35.467.37
Change in Accounts Receivable
-9.12-9.12-23.0334.45-69.41-101.89
Change in Inventory
-16.93-16.93-45.59-79.38-153.14-56.99
Change in Accounts Payable
-42.4-42.4-6.19-26.0497.47151.35
Change in Other Net Operating Assets
-0.09-0.09----
Operating Cash Flow
65.23156.51177.93221.85120.57173.9
Operating Cash Flow Growth
-73.01%-12.04%-19.80%84.00%-30.67%25.59%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-96.44-104.45-111.3-163.47-271.91-310.85
Sale of Property, Plant & Equipment
-0.170.110.040.190.190.21
Investment in Securities
0.07-3.94-2.25-1895.69-114.72
Other Investing Activities
16.0149.85-6.465.81-1.81-6.94
Investing Cash Flow
-80.53-58.42-119.97-175.47-177.85-432.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---330--
Long-Term Debt Issued
-505.18270.1-235.05219.8
Total Debt Issued
468.93505.18270.1330235.05219.8
Short-Term Debt Repaid
----271.7--
Long-Term Debt Repaid
--321.3-300.94-0.63-103.15-151
Lease Payments
-0.94-0.94-0.94-0.63--
Total Debt Repaid
-530.7-321.3-300.94-272.33-103.15-151
Net Debt Issued (Repaid)
-61.77183.88-30.8457.67131.968.8
Issuance of Common Stock
---473.93--
Repurchase of Common Stock
-50.01-50.01----
Common Dividends Paid
-62.63-90.62-84.22-57.45-37.67-19.97
Other Financing Activities
88.737.26.84-4.230.69-11.8
Financing Cash Flow
-85.6850.45-108.22469.9394.9237.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-66.42-17.4610.847.9537.18-10.63
Net Cash Flow
-167.39131.08-39.42524.2574.82-232

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-31.252.0666.6258.38-151.35-136.95
Free Cash Flow Growth
--21.85%14.12%---
Free Cash Flow Margin
-4.12%6.57%8.38%7.15%-19.80%-24.04%
Free Cash Flow Per Share
-0.040.060.080.07-0.19-0.17
Levered Free Cash Flow
-107.39-19.8-64-108.01-179.91-29.41
Unlevered Free Cash Flow
-101.31-14.75-59.15-103.01-176.09-28.49
Free Cash Flow After Leases
-32.1451.1265.6857.75-151.35-136.95

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
5.4840.8913.09-1.396.3516.06
Change in Working Capital
-71.9-71.9-77.34-74.54-114.96-7.29